ALACT.PA
Price:
$0.25
Market Cap:
$3.94M
Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Industry
Biotechnology
IPO Date
2021-11-01
Stock Exchange
PAR
Ticker
ALACT.PA
According to Acticor Biotech SAS’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -99.92% compared to the average of -268.26 of the last 4 quarters.
The mean historical PE Ratio of Acticor Biotech SAS over the last ten years is -11.92. The current -0.22 PE Ratio has changed 85.61% with respect to the historical average. Over the past ten years (40 quarters), ALACT.PA's PE Ratio was at its highest in in the June 2010 quarter at 40.16. The PE Ratio was at its lowest in in the December 2023 quarter at -1069.60.
Average
-11.92
Median
-5.27
Minimum
-49.37
Maximum
-1.88
Discovering the peaks and valleys of Acticor Biotech SAS PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 186.58%
Maximum Annual PE Ratio = -1.88
Minimum Annual Increase = -302.58%
Minimum Annual PE Ratio = -49.37
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -1.88 | -59.96% |
| 2022 | -4.69 | 65.91% |
| 2021 | -2.83 | -51.76% |
| 2020 | -5.86 | -19.83% |
| 2019 | -7.31 | 102.29% |
| 2018 | -3.61 | 60.31% |
| 2017 | -2.25 | -95.44% |
| 2016 | -49.37 | 186.58% |
| 2015 | -17.23 | -28.72% |
| 2014 | -24.17 | -302.58% |
The current PE Ratio of Acticor Biotech SAS (ALACT.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.13
5-year avg
-4.51
10-year avg
-11.92
Acticor Biotech SAS’s PE Ratio is less than Hybrigenics S.A. (-0.21), less than NOXXON Pharma N.V. (-0.00), greater than Quantum Genomics S.A. (-0.79), greater than Lysogene S.A. (-0.34), less than Deinove S.A. (-0.11), less than PHAXIAM Therapeutics S.A. (-0.02), less than TheraVet S.A. (-0.17), greater than Medesis Pharma S.A. (-0.44), less than Neovacs S.A. (-0.00), less than Pharnext S.A. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.21 | $3.95M | |
| -0.00 | $0 | |
| -0.79 | $5.00M | |
| -0.34 | $4.95M | |
| -0.11 | $1.13M | |
| -0.02 | $1.01M | |
| -0.17 | $10.02M | |
| -0.44 | $1.80M | |
| -0.00 | $6.58K | |
| -0.00 | $1.19K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acticor Biotech SAS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acticor Biotech SAS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acticor Biotech SAS's PE Ratio?
How is the PE Ratio calculated for Acticor Biotech SAS (ALACT.PA)?
What is the highest PE Ratio for Acticor Biotech SAS (ALACT.PA)?
What is the 3-year average PE Ratio for Acticor Biotech SAS (ALACT.PA)?
What is the 5-year average PE Ratio for Acticor Biotech SAS (ALACT.PA)?
How does the current PE Ratio for Acticor Biotech SAS (ALACT.PA) compare to its historical average?